Angela Hartley Brodie, Ph.D. is a cancer researcher at the University of Maryland School of Medicine in the department of Pharmacology and Experimental Therapeutics. She works in the University of Maryland Greenebaum Cancer Center's Hormone Responsive Cancers research program. Dr. Brodie is renowned for her groundbreaking work in the development of aromatase inhibitors used in the treatment of breast cancer.
Read article at Wikipedia
